Skip to main content
Erschienen in: Reactions Weekly 1/2020

01.06.2020 | Case report

Dasatinib/imatinib

Ulcerative colitis: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Peng Y, et al. An Aggressive Approach Toward a Case of Refractory Ulcerative Colitis with Uncertain Etiology in the Context of Chronic Myeloid Leukemia. Inflammatory Bowel Diseases 26: E26-E27, No. 4, Apr 2020. Available from: URL: http://doi.org/10.1093/ibd/izaa016 Peng Y, et al. An Aggressive Approach Toward a Case of Refractory Ulcerative Colitis with Uncertain Etiology in the Context of Chronic Myeloid Leukemia. Inflammatory Bowel Diseases 26: E26-E27, No. 4, Apr 2020. Available from: URL: http://​doi.​org/​10.​1093/​ibd/​izaa016
Metadaten
Titel
Dasatinib/imatinib
Ulcerative colitis: case report
Publikationsdatum
01.06.2020
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2020
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-020-79884-0

Weitere Artikel der Ausgabe 1/2020

Reactions Weekly 1/2020 Zur Ausgabe

Case report

Pembrolizumab